Ascendis Pharma A/S

Filed a patent for "effective doses of cnp conjugates" on Tue, May 7, 2024

Filed a patent for "long-acting pth compound treatments" on Tue, March 19, 2024

Filed a patent for "prodrug comprising a drug linker conjugate" on Thu, October 20, 2022

Filed a patent for "conjugates undergoing intramolecular rearrangements" on Thu, April 13, 2023

Filed a patent for "auto injector with adaptable air-shot mechanism" on Thu, January 19, 2023

Filed a patent for "prevention and treatment of ocular conditions" on Thu, April 13, 2023

Filed a patent for "il-2 sequences and uses thereof" on Thu, June 8, 2023

Filed a patent for "conjugate comprising an il-2 moiety" on Thu, June 29, 2023

Filed a patent for "hydrogel irradiation" on Thu, August 3, 2023

Filed a patent for "auto injector with cartridge locking system" on Thu, March 9, 2023

Filed a patent for "controlled-release pth compound" on Thu, August 10, 2023

Filed a patent for "biodegradable polyethylene glycol based water-insoluble hydrogels" on Thu, April 20, 2023

Filed a patent for "conjugates comprising reversible linkers and uses thereof" on Thu, March 7, 2024

Filed a patent for "glycosylated il-2 proteins and uses thereof" on Thu, October 26, 2023

Filed a patent for "hydrogel cross-linked hyaluronic acid prodrug compositions and methods" on Thu, December 28, 2023

Filed a patent for "improvement of physical and mental well-being of patients with hypoparathyroidism" on Thu, November 16, 2023

Filed a patent for "auto injector with charger safety" on Thu, October 26, 2023

Filed a patent for "prodrug comprising a drug linker conjugate" on Thu, February 8, 2024